BPGAM
UTHR icon

BTG Pactual Global Asset Management’s United Therapeutics UTHR Stock Holding History

BTG Pactual Global Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,300
Closed -$400K – 205
2015
Q2 		$400K Sell
2,300
-700
-23% -$126K 0.03% 164
2015
Q1 		$517K Buy
+3,000
New +$457K 0.04% 146
2014
Q4 		– Sell
-1,770
Closed -$228K – 229
2014
Q3 		$228K Sell
1,770
-1,730
-49% -$178K 0.03% 196
2014
Q2 		$310K Buy
+3,500
New +$337K 0.04% 197

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BTG Pactual Global Asset Management's UTHR Position: Q3 2015 in Review

BTG Pactual Global Asset Management sold out of United Therapeutics (UTHR) in Q3 2015, closing a stake of 2,300 shares — an estimated $400K sold.

BTG Pactual Global Asset Management first reported a position in UTHR in Q2 2014 and held it in 4 quarters. The position peaked at $517K in Q1 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2015.

  • BTG Pactual Global Asset Management reported no remaining United Therapeutics position as of Q3 2015 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 2,300 United Therapeutics shares in Q3 2015, an estimated $400K.
  • BTG Pactual Global Asset Management first reported a position in United Therapeutics in Q2 2014 and held it in 4 quarters.
  • BTG Pactual Global Asset Management's United Therapeutics position peaked at $517K in Q1 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.